{"id":569411,"date":"2025-12-02T03:30:55","date_gmt":"2025-12-02T03:30:55","guid":{"rendered":"https:\/\/www.olympiajournal.com\/news\/story\/569411\/oligonucleotide-synthesis-market-forecast-20252030-growth-trends-key-drivers-future-outlook.html"},"modified":"2025-12-02T03:30:55","modified_gmt":"2025-12-02T03:30:55","slug":"oligonucleotide-synthesis-market-forecast-20252030-growth-trends-key-drivers-future-outlook","status":"publish","type":"post","link":"https:\/\/www.olympiajournal.com\/news\/story\/569411\/oligonucleotide-synthesis-market-forecast-20252030-growth-trends-key-drivers-future-outlook.html","title":{"rendered":"Oligonucleotide Synthesis Market Forecast 2025\u20132030: Growth Trends, Key Drivers &amp; Future Outlook"},"content":{"rendered":"<div style=\"float:right;width:250px;padding:8px 10px 10px 10px\">\n<div><a rel=\"nofollow noopener\" href=\"https:\/\/www.abnewswire.com\/upload\/2025\/12\/1764589313.jpg\" style=\"border:none !important\" target=\"_blank\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-29\" title=\"Oligonucleotide Synthesis Market Forecast 2025&ndash;2030: Growth Trends, Key Drivers &amp; Future Outlook\" src=\"https:\/\/www.abnewswire.com\/upload\/2025\/12\/1764589313.jpg\" alt=\"Oligonucleotide Synthesis Market Forecast 2025&ndash;2030: Growth Trends, Key Drivers &amp; Future Outlook\" width=\"225\" height=\"225\" style=\"padding:0px 0px 10px 10px;border:0 solid !important\" \/><\/a><\/div>\n<div class=\"quotes\">\n<div>Europe ranks second in terms of growth. The key revenue contributing countries include Germany, UK, and France.<\/div>\n<\/div>\n<\/div>\n<div style=\"font-style:italic;padding:8px 0px\">The global oligonucleotide synthesis market is projected to grow from US$10.5 billion in 2025 to US$24.7 billion by 2030 at a CAGR of 18.6%. Explore key trends, drivers, opportunities, and leading companies shaping this booming sector.<\/div>\n<p style=\"text-align: justify\"><strong>Why Oligonucleotide Synthesis Matters in 2025<\/strong><\/p>\n<p style=\"text-align: justify\">The <strong>global <\/strong><a rel=\"nofollow\" href=\"https:\/\/www.marketsandmarkets.com\/Market-Reports\/oligonucleotide-synthesis-market-200829350.html\"><strong>oligonucleotide synthesis market<\/strong><\/a> is entering a high-growth phase, fueled by advancements in <strong>genomics, therapeutics, and diagnostics<\/strong>. Valued at <strong>US$8.9 billion in 2024<\/strong>, the market reached <strong>US$10.5 billion in 2025<\/strong> and is expected to skyrocket to <strong>US$24.7 billion by 2030<\/strong>, reflecting an impressive <strong>CAGR of 18.6%<\/strong>.<\/p>\n<p style=\"text-align: justify\">As precision medicine, genetic testing, and RNA-based therapeutics reshape modern healthcare, the demand for high-quality <strong>synthesized oligonucleotides<\/strong> is accelerating worldwide. This surge underscores their pivotal role in <strong>drug discovery, disease diagnosis, and personalized treatment pathways.<\/strong><\/p>\n<p style=\"text-align: justify\"><a rel=\"nofollow\" href=\"https:\/\/www.marketsandmarkets.com\/pdfdownloadNew.asp?id=200829350\"><strong>Download PDF Brochure:<\/strong><\/a><\/p>\n<p style=\"text-align: justify\"><strong>Market Growth Insights &amp; Trends<\/strong><\/p>\n<p style=\"text-align: justify\">The oligonucleotide synthesis market is witnessing rapid expansion, supported by:<\/p>\n<ul style=\"text-align: justify\">\n<li><strong>Strong CAGR (2025&ndash;2030):<\/strong> 18.6%<\/li>\n<li><strong>Forecasted valuation by 2030:<\/strong> US$24.7 billion<\/li>\n<li><strong>Key industries adopting oligonucleotides:<\/strong> pharmaceuticals, biotechnology, diagnostics, and academic research<\/li>\n<\/ul>\n<p style=\"text-align: justify\"><strong>Trending applications<\/strong> include:<\/p>\n<ul style=\"text-align: justify\">\n<li><strong>Gene editing technologies<\/strong> (CRISPR-Cas9)<\/li>\n<li><strong>RNA-based drugs<\/strong> (mRNA vaccines, antisense therapies, siRNA therapies)<\/li>\n<li><strong>Companion diagnostics and biomarker discovery<\/strong><\/li>\n<li><strong>Synthetic biology &amp; molecular diagnostics<\/strong><\/li>\n<\/ul>\n<p style=\"text-align: justify\"><strong>Key Drivers of Market Growth<\/strong><\/p>\n<ol style=\"text-align: justify\">\n<li><strong>Rising Demand for RNA Therapeutics<\/strong>\n<ul>\n<li>mRNA vaccines and <strong>RNA interference (RNAi)<\/strong> therapies are expanding the role of oligonucleotides in healthcare.<\/li>\n<\/ul>\n<\/li>\n<li><strong>Advancements in Genomic Research<\/strong>\n<ul>\n<li>Growing adoption of <strong>next-generation sequencing (NGS)<\/strong> and <strong>synthetic biology<\/strong> is creating a higher need for custom oligonucleotide synthesis.<\/li>\n<\/ul>\n<\/li>\n<li><strong>Personalized &amp; Precision Medicine<\/strong>\n<ul>\n<li>Tailored therapeutics and diagnostics depend on accurate oligonucleotide sequences, boosting demand.<\/li>\n<\/ul>\n<\/li>\n<li><strong>Biotech &amp; Pharma Industry Expansion<\/strong>\n<ul>\n<li>Increased investments in <strong>biotech R&amp;D<\/strong> and drug pipelines are fueling large-scale oligonucleotide production.<\/li>\n<\/ul>\n<\/li>\n<\/ol>\n<p style=\"text-align: justify\"><strong>Challenges &amp; Opportunities<\/strong><\/p>\n<p style=\"text-align: justify\"><strong>Challenges:<\/strong><\/p>\n<ul style=\"text-align: justify\">\n<li><strong>High cost of synthesis technologies<\/strong><\/li>\n<li><strong>Complex regulatory landscape<\/strong> for nucleic acid-based drugs<\/li>\n<li><strong>Quality control and scalability issues<\/strong> in manufacturing<\/li>\n<\/ul>\n<p style=\"text-align: justify\"><strong>Opportunities:<\/strong><\/p>\n<ul style=\"text-align: justify\">\n<li>Growth in <strong>custom oligonucleotide services<\/strong> for research labs and biotech startups<\/li>\n<li>Expansion of <strong>therapeutic oligonucleotides<\/strong> in oncology and rare diseases<\/li>\n<li>Integration of <strong>AI &amp; automation in oligonucleotide synthesis<\/strong> to reduce costs and enhance efficiency<\/li>\n<\/ul>\n<p style=\"text-align: justify\"><a rel=\"nofollow\" href=\"https:\/\/www.marketsandmarkets.com\/requestsampleNew.asp?id=200829350\"><strong>Request Sample Pages : <\/strong><\/a><\/p>\n<p style=\"text-align: justify\"><strong>Competitive Landscape: Key Players<\/strong><\/p>\n<p style=\"text-align: justify\">The oligonucleotide synthesis market is highly competitive, with major companies investing heavily in R&amp;D and advanced manufacturing platforms. Leading players include:<\/p>\n<ul style=\"text-align: justify\">\n<li><strong>Agilent Technologies<\/strong><\/li>\n<li><strong>Thermo Fisher Scientific<\/strong><\/li>\n<li><strong>Integrated DNA Technologies (IDT)<\/strong><\/li>\n<li><strong>Merck KGaA<\/strong><\/li>\n<li><strong>Eurofins Genomics<\/strong><\/li>\n<li><strong>Twist Bioscience<\/strong><\/li>\n<li><strong>Bio-Synthesis Inc.<\/strong><\/li>\n<\/ul>\n<p style=\"text-align: justify\"><strong>Future Outlook: Oligonucleotide Synthesis Market by 2030<\/strong><\/p>\n<p style=\"text-align: justify\">Looking ahead, the <strong>future of the oligonucleotide synthesis industry<\/strong> will be shaped by:<\/p>\n<ul style=\"text-align: justify\">\n<li><strong>Wider adoption of RNA-based drugs<\/strong> beyond COVID-19 vaccines<\/li>\n<li><strong>Innovations in synthetic biology<\/strong> enabling advanced therapeutic platforms<\/li>\n<li><strong>Increased clinical validation of antisense and siRNA therapies<\/strong><\/li>\n<li><strong>Partnerships between pharma, biotech, and contract manufacturers<\/strong> to scale production<\/li>\n<\/ul>\n<p style=\"text-align: justify\">By <strong>2030<\/strong>, oligonucleotides are expected to play a <strong>mainstream role in personalized medicine<\/strong>, reshaping drug pipelines and diagnostic strategies globally.<\/p>\n<p style=\"text-align: justify\"><strong>Conclusion &amp; Call-to-Action<\/strong><\/p>\n<p style=\"text-align: justify\">The <strong>oligonucleotide synthesis market<\/strong> is on track to nearly triple in value by 2030, making it one of the most dynamic segments in biotechnology. With applications spanning <strong>therapeutics, diagnostics, and genomics<\/strong>, this sector represents a prime opportunity for <strong>investors, biotech firms, and healthcare innovators<\/strong>.<\/p>\n<p style=\"text-align: justify\"><strong>Businesses that invest in advanced oligonucleotide synthesis today will lead the future of precision medicine tomorrow.<\/strong><\/p>\n<p style=\"text-align: justify\">For more information, <a rel=\"nofollow noopener\" href=\"https:\/\/www.marketsandmarkets.com\/Enquiry_Before_BuyingNew.asp?id=200829350\" target=\"_blank\"><strong>Inquire Now!<\/strong><\/a><\/p>\n<p style=\"text-align: justify\"><strong>FAQs <\/strong><\/p>\n<p style=\"text-align: justify\"><strong>1. What is driving growth in the oligonucleotide synthesis market?<\/strong> The market is driven by the rising use of oligonucleotides in <strong>RNA-based drugs, diagnostics, and personalized medicine.<\/strong><\/p>\n<p style=\"text-align: justify\"><strong>2. How big will the oligonucleotide synthesis market be by 2030?<\/strong> It is projected to reach <strong>US$24.7 billion by 2030<\/strong>, growing at a CAGR of <strong>18.6%.<\/strong><\/p>\n<p style=\"text-align: justify\"><strong>3. Which companies are leading in oligonucleotide synthesis?<\/strong> Key players include <strong>Thermo Fisher Scientific, Agilent Technologies, Integrated DNA Technologies, Merck KGaA, and Twist Bioscience.<\/strong><\/p>\n<p style=\"text-align: justify\"><strong>4. What are the challenges in oligonucleotide synthesis?<\/strong> Challenges include <strong>high production costs, regulatory complexity, and scalability issues.<\/strong><\/p>\n<p style=\"text-align: justify\"><strong>5. How are oligonucleotides used in therapeutics?<\/strong> They are applied in <strong>mRNA vaccines, antisense therapies, siRNA treatments, and precision medicine<\/strong><\/p>\n<p class=\"caps\"><span style='font-size:18px !important'>Media Contact<\/span><br \/><strong>Company Name:<\/strong> <a rel=\"nofollow\" href=\"https:\/\/www.abnewswire.com\/companyname\/marketsandmarkets.com_145966.html\">MarketsandMarkets\u2122 Research Private Ltd.<\/a><br \/><strong>Contact Person:<\/strong> Mr. Rohan Salgarkar<br \/><strong>Email:<\/strong> <a rel=\"nofollow\" href=\"https:\/\/www.abnewswire.com\/email_contact_us.php?pr=oligonucleotide-synthesis-market-forecast-20252030-growth-trends-key-drivers-future-outlook\">Send Email<\/a><br \/><strong>Phone:<\/strong> 18886006441<br \/><strong>Address:<\/strong>1615 South Congress Ave.  Suite 103, Delray Beach, FL 33445<br \/><strong>City:<\/strong> Florida<br \/><strong>State:<\/strong> Florida<br \/><strong>Country:<\/strong> United States<br \/><strong>Website:<\/strong> <a rel=\"nofollow noopener\" href=\"https:\/\/www.marketsandmarkets.com\/Market-Reports\/oligonucleotide-synthesis-market-200829350.html\" target=\"_blank\">https:\/\/www.marketsandmarkets.com\/Market-Reports\/oligonucleotide-synthesis-market-200829350.html<\/a><\/p>\n<p><img decoding=\"async\" src=\"https:\/\/www.abnewswire.com\/press_stat.php?pr=oligonucleotide-synthesis-market-forecast-20252030-growth-trends-key-drivers-future-outlook\" alt=\"\" width=\"1px\" height=\"1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Europe ranks second in terms of growth. The key revenue contributing countries include Germany, UK, and France. The global oligonucleotide synthesis market is projected to grow from US$10.5 billion in<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"_links":{"self":[{"href":"https:\/\/www.olympiajournal.com\/news\/wp-json\/wp\/v2\/posts\/569411"}],"collection":[{"href":"https:\/\/www.olympiajournal.com\/news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.olympiajournal.com\/news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.olympiajournal.com\/news\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.olympiajournal.com\/news\/wp-json\/wp\/v2\/comments?post=569411"}],"version-history":[{"count":0,"href":"https:\/\/www.olympiajournal.com\/news\/wp-json\/wp\/v2\/posts\/569411\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.olympiajournal.com\/news\/wp-json\/wp\/v2\/media?parent=569411"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.olympiajournal.com\/news\/wp-json\/wp\/v2\/categories?post=569411"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.olympiajournal.com\/news\/wp-json\/wp\/v2\/tags?post=569411"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}